Pharmacological treatment and impairment of pulmonary function in patients with type 2 diabetes: A cross-sectional study
Introduction: There is no clear relationship between type 2 diabetes mellitus and lung function decline; it is also unclear whether the type of treatment can modify spirometric variables and levels of inflammatory biomarkers. Objectives: To compare pulmonary function in patients with type 2 diabetes...
- Autores:
- Tipo de recurso:
- Fecha de publicación:
- 2016
- Institución:
- Universidad del Rosario
- Repositorio:
- Repositorio EdocUR - U. Rosario
- Idioma:
- eng
- OAI Identifier:
- oai:repository.urosario.edu.co:10336/23542
- Acceso en línea:
- https://doi.org/10.7705/biomedica.v36i3.2752
https://repository.urosario.edu.co/handle/10336/23542
- Palabra clave:
- C reactive protein
Insulin
Interleukin 6
Tumor necrosis factor
Chemistry
Complication
Cross-sectional study
Forced expiratory volume
Human
Immunology
Lung
Metabolism
Non insulin dependent diabetes mellitus
Pathophysiology
Physiology
Procedures
Spirometry
C-Reactive Protein
Cross-Sectional Studies
Forced Expiratory Volume
Humans
Insulin
Interleukin-6
Lung
Spirometry
Tumor Necrosis Factor-alpha
Diabetes mellitus
Inflammation
Insulins
Lung
Metformin
human
IL6 protein
Type 2
Diabetes Mellitus
- Rights
- License
- Abierto (Texto Completo)